Showing results (1771-1780 of 1,873) with videos related to
Sort By:
Pageof 188
Journal of the American College of Cardiology|January 4, 2023
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic CardiomyopathyMartin S Maron, Ahmad Masri, Lubna Choudhury, et al.Journal of the American College of Cardiology|November 13, 2020
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert PanelMitchell A Psotka, William T Abraham, Mona Fiuzat, et al.Circulation|October 12, 2020
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HFPardeep S Jhund, Scott D Solomon, Kieran F Docherty, et al.Circulation|June 25, 2023
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled TrialScott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, et al.JACC. Advances|September 2, 2025
Epicardial adipose tissue, functional status and invasive hemodynamics in heart failure with preserved ejection fractionYoran Crum, Dirk J van Veldhuisen, Sanjiv J Shah, et al.Circulation|September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HFKieran F Docherty, Pardeep S Jhund, Inder Anand, et al.JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.European Journal of Heart Failure|April 12, 2023
Geographic differences in patients with acute myocardial infarction in the PARADISE-MI trialJawad H Butt, Brian L Claggett, Zi M Miao, et al.American Heart Journal|September 5, 2024
Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trialsSheldon E Litwin, Jan Komtebedde, Barry A Borlaug, et al.Journal of the American College of Cardiology|June 12, 2024
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Francesco Cappelli, Christian Nitsche, et al.Pageof 188